Lipocine Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018	2017	2016	2015	2014	2013 - 2011
Net Income	-16.35	-10.76	-0.63	-20.96	-13.01	-11.66	-20.98	-18.97	-18.21	-20.37	Upgrade
Depreciation & Amortization	0.03	0.01	0	0	0.02	0.02	0.03	0.03	0.03	0.01	Upgrade
Share-Based Compensation	0.65	0.64	0.6	1.37	1.04	1.46	2.72	2.37	1.15	1.89	Upgrade
Other Operating Activities	3.8	-1.86	-4.38	4.28	0.29	-1.9	1.54	-1.72	1.67	1.16	Upgrade
Operating Cash Flow	-11.87	-11.97	-4.41	-15.3	-11.67	-12.08	-16.7	-18.28	-15.36	-17.3	Upgrade
Capital Expenditures	-0.01	-0.13	-0.01	0	0	0	0	-0.06	-0.03	-0.06	Upgrade
Change in Investments	13.1	14.43	-43.77	3.89	3	11.29	3.13	3.3	-24.99	0	Upgrade
Other Investing Activities	-	-	-	-	-	0.01	-	-0.01	-	0.02	Upgrade
Investing Cash Flow	13.08	14.29	-43.78	3.89	3	11.29	3.13	3.23	-25.02	-0.04	Upgrade
Share Issuance / Repurchase	0.4	0.19	30.26	22.33	13.65	0.65	11.23	0.61	32.72	0.02	Upgrade
Debt Issued / Paid	0	-2.32	-3.33	-1.43	-3.33	10	0	0	0	0	Upgrade
Other Financing Activities	-	-	-	-	-	-	-	-	-	-0.27	Upgrade
Financing Cash Flow	0.4	-2.13	26.92	20.9	10.32	10.65	11.23	0.61	32.72	-0.26	Upgrade
Net Cash Flow	1.62	0.2	-21.27	9.49	1.65	9.87	-2.35	-14.45	-7.66	-17.6	Upgrade
Free Cash Flow	-11.88	-12.1	-4.42	-15.3	-11.67	-12.08	-16.7	-18.34	-15.38	-17.36	Upgrade
Free Cash Flow Margin	-	-2420.53%	-27.38%	-	-7070.86%	-2821.95%	-	-	-	-	Upgrade
Free Cash Flow Per Share	-2.25	-2.31	-0.86	-4.67	-7.66	-9.62	-14.16	-17.08	-15.88	-23.12	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).